YYC-17393-97848
2 vaccinations
4 coded responses
21 check-ins
4 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 56-60
- ZIP prefix
- 700 / LA
- Registered
- 2021-03-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-15
Registered in v-safe
-
2021-03-15
Dose 1 — Moderna
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-22
-
2021-03-29
Survey response — day 14, dose 1MedDRA: Headache, SARS-CoV-2 test positive — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Headaches. Although the headaches were common for roughly six months after I tested positive for COVID they started becoming infrequent. Approx 4 days after the first dose I started experiencing the headaches daily again.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-29
Report sent to call center — day 14, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-05
- 2021-04-12
-
2021-04-13
Dose 2 — Moderna
-
2021-04-19
Survey response — days 1–6 daily, dose 2MedDRA: Chills, Fatigue, Headache, Pyrexia — Feeling: Good · HeadacheFree text: Within 6 hours after I received the 2nd dose I experienced severe fatigue and moderate chills that lasted approximately 36 hours. I experienced 102 degree fever for roughly 4 hours. I experienced a severe headache that lasted 48 to 56 hours.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-20
-
2021-04-27
Survey response — day 14, dose 2MedDRA: Headache, Pre-existing disease — Feeling: GoodFree text: Headaches had decreased to once or twice a week. Since 2nd shot headaches have increased to everyday again.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-04
- 2021-05-11
- 2021-05-18
-
2021-05-25
Survey response — day 42, dose 2MedDRA: Oropharyngeal pain, Sluggishness — Feeling: FairFree text: Sluggish. Minor sore throat.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-13
- 2021-10-12
- 2022-01-14
- 2022-04-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-15 | Moderna | |
| 2 | 2021-04-13 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-29 | Unsuccessful |
Free text
Release 6 — day 14, dose 1
Symptoms: Headaches. Although the headaches were common for roughly six months after I tested positive for COVID they started becoming infrequent. Approx 4 days after the first dose I started experiencing the headaches daily again.
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Within 6 hours after I received the 2nd dose I experienced severe fatigue and moderate chills that lasted approximately 36 hours. I experienced 102 degree fever for roughly 4 hours. I experienced a severe headache that lasted 48 to 56 hours.
Release 8 — day 14, dose 2
Symptoms: Headaches had decreased to once or twice a week. Since 2nd shot headaches have increased to everyday again.
Release 8 — day 42, dose 2
Symptoms: Sluggish. Minor sore throat.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test positive | ✓ | ✓ | ✓ |
| SD | Sluggishness | ✓ | ✓ | ✓ |
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release